BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2338648)

  • 21. Effect of ring size in R-(+)-pulegone-mediated hepatotoxicity: studies on the metabolism of R-(+)-4-methyl-2-(1-methylethylidene)-cyclopentanone and DL-camphorone in rats.
    Thulasiram HV; Bhat VB; Madyastha MK
    Drug Metab Dispos; 2001 Jun; 29(6):821-9. PubMed ID: 11353750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
    Kramer RA; Schuller HM; Smith AC; Boyd MR
    J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of rat liver proteins adducted by reactive metabolites of menthofuran.
    Khojasteh SC; Hartley DP; Ford KA; Uppal H; Oishi S; Nelson SD
    Chem Res Toxicol; 2012 Nov; 25(11):2301-9. PubMed ID: 23106769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular response of Musca domestica L. to Mintostachys verticillata essential oil, (4R)+-pulegone and menthone.
    Rossi YE; Canavoso L; Palacios SM
    Fitoterapia; 2012 Mar; 83(2):336-42. PubMed ID: 22155595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotransformations of R-(+)-pulegone and menthofuran in vitro: chemical basis for toxicity.
    Madyastha KM; Raj CP
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1086-92. PubMed ID: 2268314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants.
    Bakerink JA; Gospe SM; Dimand RJ; Eldridge MW
    Pediatrics; 1996 Nov; 98(5):944-7. PubMed ID: 8909490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats.
    Vadiraja BB; Gaikwad NW; Madyastha KM
    Biochem Biophys Res Commun; 1998 Aug; 249(2):428-31. PubMed ID: 9712713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of selenium deficiency and glutathione-modulating agents on diquat toxicity and lipid peroxidation in rats.
    Awad JA; Burk RF; Roberts LJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):858-64. PubMed ID: 7932197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins.
    McClanahan RH; Thomassen D; Slattery JT; Nelson SD
    Chem Res Toxicol; 1989; 2(5):349-55. PubMed ID: 2519826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
    Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the metabolism of a monoterpene ketone, R-(+)-pulegone--a hepatotoxin in rat: isolation and characterization of new metabolites.
    Madyastha KM; Raj CP
    Xenobiotica; 1993 May; 23(5):509-18. PubMed ID: 8342298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Nakahori Y; Yamamoto K
    Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive intermediates in the oxidation of menthofuran by cytochromes P-450.
    Thomassen D; Knebel N; Slattery JT; McClanahan RH; Nelson SD
    Chem Res Toxicol; 1992; 5(1):123-30. PubMed ID: 1581528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative disposition of (R)-(+)-pulegone in B6C3F1 mice and F344 rats.
    Chen LJ; Lebetkin EH; Burka LT
    Drug Metab Dispos; 2003 Jul; 31(7):892-9. PubMed ID: 12814966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo studies on the metabolism of the monoterpene pulegone in humans using the metabolism of ingestion-correlated amounts (MICA) approach: explanation for the toxicity differences between (S)-(-)- and (R)-(+)-pulegone.
    Engel W
    J Agric Food Chem; 2003 Oct; 51(22):6589-97. PubMed ID: 14558782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
    Ueno S; Susa N; Furukawa Y; Sugiyama M
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.